28.5 C
New York
Thursday, June 18, 2026

Tag: background

newssourceFORcompanyinformationcontent1marketreleases

BioCity’s ETA-Selective Antagonist SC0062 Granted Breakthrough Therapy Designation in China for Diabetic Kidney Disease with Albuminuria

Second BTD Recognition Highlights Compound's Potential as Next-Generation Broad-Spectrum Renal TherapySHANGHAI, June 25, 2025 /PRNewswire/ -- BioCity Biopharma ("BioCity") announced today that the Center for...

DHODH Inhibitors Market Forecast to Reach New Heights by 2034 Owing to the Expanding Applications in Oncology and Autoimmune Diseases | DelveInsight

The DHODH inhibitor market is poised for steady growth, fueled by the rising burden of autoimmune and inflammatory diseases, along with increasing interest in...

DHODH Inhibitors Market Forecast to Reach New Heights by 2034 Owing to the Expanding Applications in Oncology and Autoimmune Diseases | DelveInsight

The DHODH inhibitor market is poised for steady growth, fueled by the rising burden of autoimmune and inflammatory diseases, along with increasing interest in...

Sun Pharma Announces Appointment of Richard Ascroft as CEO North America

PRINCETON, N.J., June 25, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes...

Guidesly Launches Jack AI™: The AI Solution for Outdoor Recreation Guides to Navigate Marketing Like A Pro

Guidesly Guides now have a New AI Tool with the Invention of Guidesly's Jack AI™Jack AI Provides the Guidesly Guide a No-Touch, AI Experience...

Dextoro Trading Wallet Launches Android App, Expanding Global Access to Crypto Trading

Miami, FL, June 25, 2025 (GLOBE NEWSWIRE) -- Dextoro, a next-generation decentralized crypto trading mobile app, today announced the official release of the Dextoro Trading Wallet app for Android. This expansion marks a major milestone in the company’s mission to deliver secure, gas-free, and user-friendly crypto trading to a global audience.

Intellectual Property Owners Education Foundation: INTELLECTUAL PROPERTY IS EVERYWHERE!

New tool is empowering creators by helping them protect their ideas by teaching the differences between patents, trademarks, copyrights and trade secrets WASHINGTON, June 25,...

Apono Expands Leadership to Accelerate Platform Innovation and Customer Experience

New VPs of R&D and Customer Experience Join to Drive Platform Expansion and Meet Growing Demand for Intelligent Cloud Access Control NEW YORK, June 25,...

Karen Renzi Joins ProofPilot as Vice President, Clinical Strategy & Solutions

NEW YORK, June 25, 2025 /PRNewswire/ -- ProofPilot, the leading end-to-end Clinical Experience Platform (CXP), is pleased to announce the appointment of Karen Renzi...

Nipocalimab showed greater sustained disease control versus approved FcRn blockers for generalised myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published...

The ITC compared all published Phase 3 data of these treatments, leveraging longitudinal results, and findings reinforce the importance of consistent, sustained disease control in managing a chronic autoantibody disease like gMG

A TASTE OF HERITAGE: FOUR POINTS BY SHERATON SINGAPORE, RIVERVIEW UNVEILS AH PUI TEOCHEW PORRIDGE BUFFET

SINGAPORE, June 25, 2025 /PRNewswire/ -- In a heartfelt tribute to Singapore's 60th birthday, Four Points by Sheraton Singapore, Riverview is proud to introduce an...

Hewelth BioClear Launches as Breakthrough In-Home Laser Solution to Support Healthier Nail Appearance

Dermatologist-Endorsed Low-Level Laser Device Introduced to Enhance Nail Appearance Through Non-Invasive At-Home Use 
Dermatologist-Endorsed Low-Level Laser Device Introduced to Enhance Nail Appearance Through Non-Invasive At-Home Use

BAFF- and APRIL-targeted Therapies Market Sees Surge in Activity Amid Rising Autoimmune Disease Burden | DelveInsight

The BAFF- and APRIL-targeted therapies market is experiencing steady growth driven by the rising prevalence of autoimmune diseases such as systemic lupus erythematosus (SLE),...

BAFF- and APRIL-targeted Therapies Market Sees Surge in Activity Amid Rising Autoimmune Disease Burden | DelveInsight

The BAFF- and APRIL-targeted therapies market is experiencing steady growth driven by the rising prevalence of autoimmune diseases such as systemic lupus erythematosus (SLE),...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsBackground

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers